StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Gerresheimer AG
XETRA:GXI.DE
Sector
Location
Market Cap
USD 2.02 B
Share Price
USD 58.14
Avg Daily Volume
243,897
Change (1 day)
2.34%
Change (1 year)
-41.98%
Change (YTD)
-21.31%
Gerresheimer AG Operating Cash Flow for the year ending November 30, 2024: USD 254.13 M
Gerresheimer AG Operating Cash Flow is USD 254.13 M for the year ending November 30, 2024, a -20.68% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
-
Gerresheimer AG Operating Cash Flow for the year ending November 30, 2023 was USD 320.39 M, a 38.73% change year over year.
-
Gerresheimer AG Operating Cash Flow for the year ending November 30, 2022 was USD 230.94 M, a -3.95% change year over year.
-
Gerresheimer AG Operating Cash Flow for the year ending November 30, 2021 was USD 240.45 M, a -9.24% change year over year.
-
Gerresheimer AG Operating Cash Flow for the year ending November 30, 2020 was USD 264.93 M, a 24.66% change year over year.
Competitors
Chugai Pharmaceutical Co., Ltd.
USD 49.71
4519.T
+0.51
1.03%
West Pharmaceutical Services, Inc.
USD 263.51
WST
-15.59
-5.59%
Dow Inc.
USD 25.51
DOW
+0.44
1.75%
Nitto Denko Corporation
USD 21.06
6988.T
-0.18
-0.83%
Nordson Corporation
USD 220.84
NDSN
+1.69
0.77%
AptarGroup, Inc.
USD 160.99
ATR
-0.83
-0.51%
Avantor, Inc.
USD 14.21
AVTR
+0.20
1.43%
Yuhan Corporation
USD 88.25
000100.KS
-1.02
-1.14%
The Supreme Industries Limited
USD 49.82
SUPREMEIND.NS
+0.75
1.54%
Gan & Lee Pharmaceuticals.
USD 8.10
603087.SS
-0.23
-2.79%
SCHOTT Pharma AG & Co. KGaA
USD 30.53
1SXP.F
+0.63
2.10%
Cohance Lifesciences Limited
USD 11.78
COHANCE.NS
-0.20
-1.66%
Zhejiang Huahai Pharmaceutical Co., Ltd.
USD 3.07
600521.SS
+0.05
1.56%
Yunnan Energy New Material Co., Ltd.
USD 4.25
002812.SZ
+0.01
0.27%
H.B. Fuller Company
USD 59.57
FUL
+0.40
0.68%
SKC Co., Ltd.
USD 75.92
011790.KS
-3.94
-4.93%
Tonghua Dongbao Pharmaceutical Co., Ltd.
USD 1.15
600867.SS
-0.01
-0.43%
Anbio Biotechnology Class A Ordinary Shares
USD 50.62
NNNN
+0.91
1.83%
Anhui Anke Biotechnology (Group) Co., Ltd.
USD 1.32
300009.SZ
-0.02
-1.44%
Shandong Pharmaceutical Glass Co., Ltd
USD 3.26
600529.SS
+0.04
1.15%
Key Data
| Date | Operating Cash Flow | Capital Expenditure | Net Cash Used For Investing Activities | Net Cash Used Provided By Financing Activities |
|---|
Competitors
Chugai Pharmaceutical Co., Ltd.
USD 49.71
4519.T
+0.51
1.03%
West Pharmaceutical Services, Inc.
USD 263.51
WST
-15.59
-5.59%
Dow Inc.
USD 25.51
DOW
+0.44
1.75%
Nitto Denko Corporation
USD 21.06
6988.T
-0.18
-0.83%
Nordson Corporation
USD 220.84
NDSN
+1.69
0.77%
AptarGroup, Inc.
USD 160.99
ATR
-0.83
-0.51%
Avantor, Inc.
USD 14.21
AVTR
+0.20
1.43%
Yuhan Corporation
USD 88.25
000100.KS
-1.02
-1.14%
The Supreme Industries Limited
USD 49.82
SUPREMEIND.NS
+0.75
1.54%
Gan & Lee Pharmaceuticals.
USD 8.10
603087.SS
-0.23
-2.79%
SCHOTT Pharma AG & Co. KGaA
USD 30.53
1SXP.F
+0.63
2.10%
Cohance Lifesciences Limited
USD 11.78
COHANCE.NS
-0.20
-1.66%
Zhejiang Huahai Pharmaceutical Co., Ltd.
USD 3.07
600521.SS
+0.05
1.56%
Yunnan Energy New Material Co., Ltd.
USD 4.25
002812.SZ
+0.01
0.27%
H.B. Fuller Company
USD 59.57
FUL
+0.40
0.68%
SKC Co., Ltd.
USD 75.92
011790.KS
-3.94
-4.93%
Tonghua Dongbao Pharmaceutical Co., Ltd.
USD 1.15
600867.SS
-0.01
-0.43%
Anbio Biotechnology Class A Ordinary Shares
USD 50.62
NNNN
+0.91
1.83%
Anhui Anke Biotechnology (Group) Co., Ltd.
USD 1.32
300009.SZ
-0.02
-1.44%
Shandong Pharmaceutical Glass Co., Ltd
USD 3.26
600529.SS
+0.04
1.15%